To: RichBear who wrote (15799 ) 12/6/1999 8:23:00 AM From: Jim Bishop Read Replies (1) | Respond to of 150070
MEHO LOS ANGELES, Dec. 6 /PRNewswire/ -- On Wednesday, December 15, 1999, principals of Meridian Holdings, Inc. and the company's Intercare Diagnostics, Inc. subsidiary will participate in the National Aeronautics and Space Administration (NASA) Langley Research Center's technology briefings, showcasing the latest in NASA-developed biofeedback technologies. The briefings, which will be held at East Virginia Medical School in Norfolk, Va., are for the purpose of introducing the technologies, allowing attendees to ask questions, and providing instructions on submitting a commercialization licensing plan to NASA. According to NASA representatives, the new technologies are suitable for incorporation into virtual reality biofeedback systems or new video games. Meridian's interest in the presentations is related to Intercare's prior work in biofeedback and self-regulation technology. Intercare Diagnostics, Inc. is a United States FDA-registered, world-renowned biomedical software development and publishing company, with currently five multimedia software titles in the market, including self-regulation software in use by the U.S. military. ''We are delighted to be participating in these briefings and enthusiastic about the licensing potential for NASA's newest biofeedback technologies, especially as they might relate to Intercare's core competencies and commercialized products,'' said Anthony C. Dike, MD, Meridian's chairman and chief executive officer. About Meridian Holdings Meridian Holdings, Inc. is an acquisition-oriented business enterprise focused on providing media-rich Internet contents and e-commerce solutions via Internet-based communities, online malls, classified advertisements and website auctions. The company's proprietary Internet software is used to provide access to a unique information portal and a virtual shopping mall featuring thousands of downloadable and traditional consumer products. The company's Intercare Diagnostics, Inc. subsidiary is a U.S. FDA-registered, biomedical software development and publishing company. Visit Meridian's web site at www.meho.com and Intercare's web site at www.intercare.com. NOTE: Statements in this news release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Material that is forward-looking may contain statements about expected future events and/or financial results that are forward-looking in nature. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties that may cause the company's results to differ from such forward-looking statements. These include, but are not limited to, economic, competitive, governmental, technological and other factors discussed in the statements and/or in the company's filings with the Securities and Exchange Commission. SOURCE: Meridian Holdings, Inc. More Quotes and News: Meridian Holdings Inc (OTC BB:MEHO.OB - news)